Jason A Incorvati MD
Breast Cancer, Hematologic Oncology
Assistant Professor, Temple University
Join to view full profile
333 Cottman AvePhiladelphia, PA 19111
Phone+1 215-728-2500
Fax+1 215-728-3639
Dr. Incorvati is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jason Incorvati is an oncologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Fox Chase Cancer Center-American Oncologic Hospital and Suburban Community Hospital. He received his medical degree from Temple University School of Medicine and has been in practice 8 years. He specializes in breast cancer and hematologic oncology and is experienced in breast cancer, hematologic oncology--lymphoma, myeloma, myelodysplasia, and benign hematology.
Education & Training
Stony Brook Medicine/University HospitalFellowship, Hematology and Medical Oncology, 2012 - 2015
University of MarylandResidency, Internal Medicine, 2009 - 2012
Lewis Katz School of Medicine at Temple UniversityClass of 2009
Certifications & Licensure
NJ State Medical License 2015 - 2027
PA State Medical License 2017 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Cold Agglutinin-Mediated Hemolytic Anemia Preceding the Diagnosis of Acute Myeloid Leukemia: A Case Report and Literature Review.Muhammad Ali Tariq, Motaz Almahmood, Javaria Mushtaq, Jason Incorvati
Cureus. 2026-04-01 - 1 citations"I Missed My Other Oncologist": Established Relationships as Barriers and Facilitators to Accessing CAR-T and Autologous Transplantation.Zachary A K Frosch, Clark Meshack, Caitlin Meeker, Asya Varshavsky-Yanovsky, Rashmi Khanal
Cancer Medicine. 2025-12-01 - 5 citationsCamizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1.Richard D Baird, Begoña Bermejo de Las Heras, Manuel Ruiz-Borrego, Christos Vaklavas, Irene Moreno
Clinical Cancer Research. 2025-10-15
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
